ArticleFrontiers in immunology2026

Complement and autoantibody levels under anifrolumab therapy in SLE: implications for clinical practice.

Jan-Gerd Rademacher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.